Charles McWherter

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Charles McWherter
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles McWherter:

Company Role Class Num Shares Value Price $ Report Date Ownership
89bio, Inc. Director Common Stock 0 $0 $14.70 30 Oct 2025 Direct
CymaBay Therapeutics, Inc. President of R&D Common Stock 0 $0 $2.94 22 Mar 2024 Direct
89bio, Inc. Director Stock Option (Right to Buy) 0 30 Oct 2025 Direct
CymaBay Therapeutics, Inc. President of R&D Employee Stock Option (right to buy) 0 22 Mar 2024 Direct

Insider Reports Filed by Charles McWherter

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ETNB 89bio, Inc. 30 Oct 2025 3 $0 4 Director 30 Oct 2025, 20:22
ETNB 89bio, Inc. 03 Feb 2025 1 $0 4 Director 05 Feb 2025, 16:01
ETNB 89bio, Inc. 21 Jan 2025 2 +$99,850 4 Director 23 Jan 2025, 19:38
ETNB 89bio, Inc. 05 Dec 2024 1 +$80,000 4 Director 09 Dec 2024, 06:01
ETNB 89bio, Inc. 05 Aug 2024 1 $0 4 Director 07 Aug 2024, 18:05
ETNB 89bio, Inc. 30 Jul 2024 0 $0 3 Director 07 Aug 2024, 18:00
/report/000095017024035470-mcwherter-charles-2024-03-22 CymaBay Therapeutics, Inc. 22 Mar 2024 13 $0 4 President of R&D 22 Mar 2024, 17:06
/report/000106299324001432-mcwherter-charles-2024-01-24 CymaBay Therapeutics, Inc. 24 Jan 2024 2 $0 4 President of R&D 26 Jan 2024, 18:29
/report/000106299324001164-mcwherter-charles-2024-01-19 CymaBay Therapeutics, Inc. 19 Jan 2024 15 -$305,123 4 President of R&D 22 Jan 2024, 18:59
/report/000106299323022793-mcwherter-charles-2023-12-18 CymaBay Therapeutics, Inc. 18 Dec 2023 8 -$186,781 4 President of R&D 18 Dec 2023, 20:04
/report/000106299323021139-mcwherter-charles-2023-11-17 CymaBay Therapeutics, Inc. 17 Nov 2023 6 -$150,583 4 President of R&D 17 Nov 2023, 17:58
/report/000106299323019549-mcwherter-charles-2023-10-18 CymaBay Therapeutics, Inc. 18 Oct 2023 7 -$197,226 4 President of R&D 18 Oct 2023, 18:22
/report/000106299323018280-mcwherter-charles-2023-09-18 CymaBay Therapeutics, Inc. 18 Sep 2023 7 -$244,003 4 President of R&D 19 Sep 2023, 18:27
/report/000106299323016871-mcwherter-charles-2023-08-18 CymaBay Therapeutics, Inc. 18 Aug 2023 7 -$140,629 4 President of R&D 18 Aug 2023, 20:03
/report/000106299323015088-mcwherter-charles-2023-07-18 CymaBay Therapeutics, Inc. 18 Jul 2023 7 -$139,774 4 President of R&D 19 Jul 2023, 18:05
/report/000106299323013932-mcwherter-charles-2023-06-20 CymaBay Therapeutics, Inc. 20 Jun 2023 7 -$68,638 4 President of R&D 21 Jun 2023, 18:46
/report/000106299323011865-mcwherter-charles-2023-05-18 CymaBay Therapeutics, Inc. 18 May 2023 7 -$88,642 4 President of R&D 19 May 2023, 18:00
/report/000106299323001492-mcwherter-charles-2023-01-25 CymaBay Therapeutics, Inc. 25 Jan 2023 1 $0 4 President of R&D 27 Jan 2023, 15:27
/report/000106299322001698-mcwherter-charles-2022-01-25 CymaBay Therapeutics, Inc. 25 Jan 2022 1 $0 4 Chief Scientific Officer 27 Jan 2022, 15:55